...
首页> 外文期刊>Clinical nephrology >Percutaneous transluminal angioplasty as first-line treatment of transplant renal artery stenosis.
【24h】

Percutaneous transluminal angioplasty as first-line treatment of transplant renal artery stenosis.

机译:经皮腔内血管成形术是移植肾动脉狭窄的一线治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Transplant renal artery stenosis (TRAS) is a frequent complication after renal transplantation, however long-term follow-up data after interventional treatment are rare. PATIENTS: In our transplant center 11 of 264 consecutive renal transplant recipients (4.17%) were diagnosed with TRAS. In addition, TRAS occurred in 2 renal transplant recipients that had been transplanted at other centers but who had their follow-up examinations in our center. Either a rise of the serum creatinine level and/or worsened systemic hypertension or routine examination with color Doppler sonography were indications for further diagnostic workup. METHODS: Direct angiography of the transplant renal artery was performed followed by percutaneous transluminal angioplasty (PTA) after the diagnosis of TRAS was confirmed in all of these patients. RESULTS: The immediate success rate for PTA was 92.3% (12/13). Only 1 patient with a severe kinking of the transplant renal artery had to undergo surgery to restore renal function. No complications occurred after the interventions. Thereafter the patients were monitored for a mean observation period of 33.15 months. Serum creatinine levels were significantly lower after the intervention, and estimated glomerular filtration rate (eGFR) increased accordingly. With regard to blood pressure there was only a trend for lower blood pressure levels and less antihypertensive use, whereas the dose of the prescribed drugs decreased significantly with time after interventional treatment of TRAS. In addition, a long-lasting rise of the hemoglobin levels could also be demonstrated. CONCLUSION: In summary, the beneficial effect of PTA of TRAS on renal function is long-lasting. Therefore, PTA, usually combined with stent placement, should be first-line treatment in TRAS in all patients. Surgical revascularization is only warranted, if PTA fails.
机译:背景:肾移植后移植肾动脉狭窄(TRAS)是一种常见的并发症,但是介入治疗后的长期随访数据很少。患者:在我们的移植中心,连续264位肾移植受者中有11位(4.17%)被诊断为TRAS。此外,在其他肾脏移植中心接受了随访检查的2名肾移植受者中,发生了TRAS。血清肌酐水平的升高和/或全身性高血压的恶化或彩色多普勒超声检查的常规检查是进一步诊断检查的指征。方法:在所有这些患者中均确诊为TRAS后,对移植肾动脉进行直接血管造影,然后进行经皮腔内血管成形术(PTA)。结果:PTA的即时成功率为92.3%(12/13)。只有1名移植肾动脉严重扭结的患者必须接受手术以恢复肾功能。干预后无并发症发生。此后,监测患者的平均观察期为33.15个月。干预后,血清肌酐水平显着降低,估计的肾小球滤过率(eGFR)也相应提高。关于血压,只有降低血压水平和较少使用降压药的趋势,而在TRAS介入治疗后,处方药的剂量却随时间显着减少。此外,还可以证明血红蛋白水平的持久上升。结论:总的来说,TRAS的PTA对肾脏功能的持久作用是持久的。因此,在所有患者中,通常应将TTA与支架置入相结合作为TRAS的一线治疗。仅当PTA失败时才需要进行手术血运重建。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号